CBD, CBG, CBDA, CBDVA, and Δ9-THC are all BCRP substrates. While BCRP inhibitor elacridar significantly inhibits the transport of CBD, CBDA, and CBDVA substrates and causes weakness of CBG and Δ9-THC substrates, CBDV transport is not inhibited by elacridar.